TRANSCEND-CKD Trademark

Trademark Overview


On Thursday, September 25, 2025, a trademark application was filed for TRANSCEND-CKD with the United States Patent and Trademark Office. The USPTO has given the TRANSCEND-CKD trademark a serial number of 99412720. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Tuesday, February 17, 2026. This trademark is owned by Eli Lilly and Company. The TRANSCEND-CKD trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of kidney disease
transcend-ckd

General Information


Serial Number99412720
Word MarkTRANSCEND-CKD
Filing DateThursday, September 25, 2025
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateTuesday, February 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical and scientific research in the field of kidney disease
Pseudo MarkTRANSCEND CKD

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 25, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Thursday, September 25, 2025NEW APPLICATION ENTERED
Thursday, September 25, 2025APPLICATION FILING RECEIPT MAILED
Friday, February 13, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 17, 2026ASSIGNED TO EXAMINER